Brief: Silo Pharma Says On June 28, Entered Amendment To That Certain Cela Entered Into By & Between Co & University Of Maryland, Baltimore Dated Feb 26, 2021
29/06/2023 22:17
June 29 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA-ON JUNE 28, ENTERED AMENDMENT TO THAT CERTAIN
CELA
ENTERED INTO BY & BETWEEN CO & UNIVERSITY OF MARYLAND, BALTIMORE
DATED FEB 26, 2021
* SILO PHARMA- PURSUANT TO AMENDMENT TERM OF CELA WAS
EXTENDED
UNTIL SEPTEMBER 30, 2023
Source text for Eikon: ID:
Further company coverage: SILO.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement